Medicare Enrolled

Dr. Kenneth Lucero, M.D.

Family Medicine · Blythe, CA
Practice pattern: Electrophysiology & Device — Practice focused on heart rhythm disorders and cardiac device management
Low-engagement
1415 W HOBSONWAY, Blythe, CA 92225
7609224981
In practice since 2007 (19 years)
NPI: 1417079989 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lucero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lucero

Dr. Kenneth Lucero is a family medicine specialist in Blythe, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lucero performed 294 Medicare services across 240 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lucero received a total of $1,645 from 25 pharmaceutical and/or device companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lucero is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 294 Medicare services $1,645 industry payments

Medicare Practice Summary

Medicare Utilization ↗
294
Medicare services
Bottom 42% in CA for family medicine
240
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
59 $38 $90
Routine 12-lead electrocardiogram (ECG)
A test that records the electrical activity of the heart using at least 12 leads to produce a tracing.
45 $4 $62
Blood glucose level test
A test that measures the amount of sugar in your blood.
43 $4 $20
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
28 $20 $93
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
28 $60 $110
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
25 $66 $95
X-ray of lower and sacral spine, minimum of 4 views
An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints.
18 $30 $163
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
18 $4 $4
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
17 $17 $125
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
13 $35 $120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,645
Total received (2018-2024)
Avg $235/year across 7 years
Top 19% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
96
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,645 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$221
2023
$143
2022
$359
2021
$138
2020
$328
2019
$154
2018
$303

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$82
Vanda Pharmaceuticals Inc.
$47
Amgen Inc.
$41
Janssen Pharmaceuticals, Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Top 3 companies account for 76.9% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$308
Novo Nordisk Inc
$164
Amgen Inc.
$126
Lilly USA, LLC
$109
Merck Sharp & Dohme Corporation
$104
Merck Sharp & Dohme LLC
$80
Novartis Pharmaceuticals Corporation
$79
Supernus Pharmaceuticals, Inc.
$72
Amarin Pharma Inc.
$67
PFIZER INC.
$56
Janssen Pharmaceuticals, Inc
$52
Vanda Pharmaceuticals Inc.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Smith+Nephew, Inc.
$40
IDORSIA PHARMACEUTICALS US INC
$39
Agile Therapeutics, Inc.
$39
Biohaven Pharmaceuticals, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
AbbVie Inc.
$31
Allergan, Inc.
$30
Horizon Therapeutics plc
$26
Prytime Medical Devices, Inc.
$20
AstraZeneca Pharmaceuticals LP
$18
Xeris Pharmaceuticals, Inc.
$16
Purdue Pharma L.P.
$11
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · Aimovig · Amitiza · BELSOMRA · CHANTIX · CREON · ELIQUIS · EMGALITY · ENTRESTO · ER-REBOA PLUS · EVENITY · GVOKE HYPOPEN · HETLIOZ · INVEGA SUSTENNA · JANUVIA · JARDIANCE · MOUNJARO · NURTEC ODT · Otezla · Ozempic · QUVIVIQ · RAYOS · REXULTI · Repatha · Rybelsus · STEGLATRO · SYMBICORT · SYMPROIC · Santyl · TRADJENTA · TROKENDI XR · Tresiba · Twirla · UBRELVY · VERQUVO · VRAYLAR · Vascepa · Victoza · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Blythe?
Compare family medicine physicians in the Blythe area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
7
Per 100K population
0.3
County median income
$89,672
Nearest hospital
PALO VERDE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lucero is an electrophysiology & device specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lucero experienced with hospital follow-up visit, low complexity?
Based on Medicare claims data, Dr. Lucero performed 59 hospital follow-up visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lucero receive payments from pharmaceutical companies?
Yes. Dr. Lucero received a total of $1,645 from 25 companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lucero's costs compare to other family medicine physicians in Blythe?
Dr. Lucero's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lucero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →